OraSure Technologies, Inc. Common Stock OSUR
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIESi
Market dataready · fetched 2026-11-04T07:37:25.301Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T21:00:00.731321811Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-04T07:37:24.270257+00:00
OraSure Technologies, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 2.85 | 83.5% | 26.4% | |||
| 25Δ | 3.01 | 83.1% | 24.5% | |||
| 30Δ | 3.17 | 82.6% | 22.6% | |||
| 35Δ | 3.33 | 82.2% | 20.7% | |||
| 40Δ | 4.43 | 123.2% | 37.7% | 3.49 | 81.7% | 18.8% |
| 45Δ | 4.21 | 124.7% | 34.0% | 3.65 | 81.3% | 16.9% |
| 50Δ | 3.98 | 126.1% | 30.3% | 3.81 | 80.8% | 15.0% |
| 55Δ | 3.76 | 127.6% | 26.6% | 3.97 | 80.4% | 13.1% |
| 60Δ | 3.54 | 129.0% | 22.9% | 4.13 | 79.9% | 11.2% |
| 65Δ | 3.32 | 130.5% | 19.3% | 4.29 | 79.5% | 9.3% |
| 70Δ | 3.10 | 131.9% | 15.6% | 4.45 | 79.0% | 7.4% |
| 75Δ | 2.88 | 133.4% | 11.9% | 4.61 | 78.6% | 5.5% |
| 80Δ | 2.66 | 134.8% | 8.2% | 4.77 | 78.1% | 3.6% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.85
- IV
- 83.5%
- B/E move
- 26.4%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.01
- IV
- 83.1%
- B/E move
- 24.5%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.17
- IV
- 82.6%
- B/E move
- 22.6%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.33
- IV
- 82.2%
- B/E move
- 20.7%
40Δ
- Pseudo strike
- 4.43
- IV
- 123.2%
- B/E move
- 37.7%
- Pseudo strike
- 3.49
- IV
- 81.7%
- B/E move
- 18.8%
45Δ
- Pseudo strike
- 4.21
- IV
- 124.7%
- B/E move
- 34.0%
- Pseudo strike
- 3.65
- IV
- 81.3%
- B/E move
- 16.9%
50Δ
- Pseudo strike
- 3.98
- IV
- 126.1%
- B/E move
- 30.3%
- Pseudo strike
- 3.81
- IV
- 80.8%
- B/E move
- 15.0%
55Δ
- Pseudo strike
- 3.76
- IV
- 127.6%
- B/E move
- 26.6%
- Pseudo strike
- 3.97
- IV
- 80.4%
- B/E move
- 13.1%
60Δ
- Pseudo strike
- 3.54
- IV
- 129.0%
- B/E move
- 22.9%
- Pseudo strike
- 4.13
- IV
- 79.9%
- B/E move
- 11.2%
65Δ
- Pseudo strike
- 3.32
- IV
- 130.5%
- B/E move
- 19.3%
- Pseudo strike
- 4.29
- IV
- 79.5%
- B/E move
- 9.3%
70Δ
- Pseudo strike
- 3.10
- IV
- 131.9%
- B/E move
- 15.6%
- Pseudo strike
- 4.45
- IV
- 79.0%
- B/E move
- 7.4%
75Δ
- Pseudo strike
- 2.88
- IV
- 133.4%
- B/E move
- 11.9%
- Pseudo strike
- 4.61
- IV
- 78.6%
- B/E move
- 5.5%
80Δ
- Pseudo strike
- 2.66
- IV
- 134.8%
- B/E move
- 8.2%
- Pseudo strike
- 4.77
- IV
- 78.1%
- B/E move
- 3.6%
Options history
No recorded observations
Medical Instruments & Supplies
PLSE
Pulse Biosciences, Inc. is a bioelectrical medicine startup. The company is headquartered in Hayward, California.
More →RGEN
Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and…
More →RMD
ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices…
More →SOLV
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.…
More →STAA
STAAR Surgical Company designs, develops, manufactures, markets and sells implantable eye lenses and supplemental delivery systems for placing the lenses in the eye. The company…
More →STVN
Stevanato Group SpA (STVN) is a leading global provider of advanced drug delivery systems, specializing in innovative glass and polymer packaging solutions designed for injectable…
More →